GLP-3 (RT)

In stock
  • Tri-agonist
  • GIP / GLP-1 / GCG
  • CAS 2381089-83-2
  • ≥ 99.0% (RP-HPLC)
  • Lyophilised powder, batch COA supplied
  • Available in 5mg, 10mg, 20mg, 30mg and 60mg vials

Triple GIP, GLP-1 and glucagon receptor agonist. Lyophilised powder for in-vitro metabolic research.

Same-day dispatch

order within —

Every UK order includes

  • 99.0% HPLC purity, independently verified
  • Batch documentation / COA with every order
  • Priority shipping — UK & EU · international available
  • Discreet, temperature-controlled packaging

£30.99

Your current kit

5 more to complete your kit

View COA

Supplied for laboratory research only. Strictly not for human or veterinary use.

Secure Checkout
  • Visa
  • Mastercard
  • Wallid
  • Bank transfer
  • BTC
  • ETH
  • USDT

Free priority shipping

On all UK orders — discreet and tracked.

Worldwide shipping

We ship across the EU & internationally, tracked to your door.

24-hour processing

Orders placed before 12pm GMT ship the same day from our UK hub.

Delivery guarantee

Lost or damaged? We reship — no questions. Order with confidence.

Bundle builder

Any 5 compounds save 15% · any 10 save 20%

Analytical data

Specifications,
verified.

Specifications for this compound, independently verified by HPLC and LC-MS before release.

Analytical specifications for GLP-3 (RT)
Property GLP-3 (RT)
Full name Retatrutide (LY3437943)
CAS number 2381089-83-2
Molecular formula C₂₂₁H₃₄₂N₄₆O₆₈
Molecular weight 4731.33 g/mol
Purity (HPLC) ≥ 99.0% (RP-HPLC)
Mass confirmation Confirmed by LC-MS
Residual moisture ≤ 5.0% (Karl Fischer)
Form Lyophilised powder
Solubility Bacteriostatic or sterile water
Storage −20°C sealed and protected from light; 2–8°C once reconstituted
Half-life Approximately 6 days, per published pharmacokinetic studies

About this peptide

GLP-3 (RT)

Retatrutide is supplied as a laboratory research material for qualified analytical and in-vitro research environments.

  • 01 Single-chain peptide

    39 amino acids carrying a C20 fatty-diacid moiety, molecular weight 4731.33 g/mol.

  • 02 Triple receptor agonist

    Activity at the GIP, GLP-1 and glucagon receptors — the first molecule of its class to reach late-stage trials.

  • 03 Published record

    Phase 2 data in The New England Journal of Medicine and The Lancet, 2023; first-in-human pharmacology in Nature Metabolism, 2022.

  • 04 Research material

    Supplied lyophilised at −20°C with a batch certificate of analysis, for analytical and in-vitro use only.

FAQ

Before you order.

Anything not covered here, ask us directly — replies within one working day.

Is a COA included with my order?
Yes. Every vial ships with a certificate of analysis tied to the lot number printed on its label, covering identity by mass spectrometry and purity by HPLC. Retained samples are held so a batch can be re-tested.
How is the product shipped?
Lyophilised powder is stable at ambient temperature in transit and ships in discreet, tracked packaging. UK and EU orders are sent on a priority service; international destinations are quoted at checkout.
How should the vial be stored on arrival?
Keep it sealed at −20°C, protected from light. Lyophilised material is stable for months under those conditions. Once reconstituted, store at 2–8°C and use within the window stated on the certificate of analysis.
Who is this product for?
Qualified researchers and laboratories only. It is supplied strictly as an analytical and in-vitro research material, and is not a medicine, a supplement or a veterinary product.
How does this differ from tirzepatide?
Retatrutide adds glucagon-receptor activity to the GIP and GLP-1 agonism tirzepatide already has, which is why it is described as a triple agonist. The two are separate compounds with separate CAS registrations.
Which vial size should I order?
All five sizes are the same compound; they differ only in the mass of lyophilised peptide per vial. Choose by the working volume your protocol needs.

More from the catalogue

TB500
Sold Out

TB500

10mg

Synthetic peptide fragment of thymosin beta-4. Supplied lyophilised for cell-based research.

£35.99

Out of stock
BPC-157 + TB500
Sold Out

BPC-157 + TB500

10mg–20mg

Blended vial of BPC-157 and thymosin beta-4 fragment. Lyophilised for in-vitro research use.

Price range: £28.99 through £36.99

Out of stock
Tirzepatide
Sold Out

Tirzepatide

30mg–60mg

Dual GIP and GLP-1 receptor agonist peptide. Supplied lyophilised for in-vitro metabolic research.

Price range: £64.99 through £99.99

Out of stock